New findings from University of Bologna in the area of artificial neural networks described

Data detailed in "Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease" have been presented. "Despite its accuracy, the model for end-stage liver disease (MELD), currently adopted to determine the prognosis of patients with liver cirrhosis, guide referral to transplant programmes and prioritise the allocation of donor organs, fails to predict mortality in a considerable proportion of patients. To evaluate the possibility to better predict 3-month liver disease-related mortality of patients awaiting liver transplantation using an artificial neural network (ANN). The ANN was constructed using data from 251 consecutive people with...

Want to see the full article?

• Purchase this article for only $3.00